BMJ 2011; 342

1491 doi: 10.1136/bmj.d1491 (Published 29 March 2011)
Research
Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial
OPEN ACCESS
Paul S Myles, professor1, director2, Philip Peyton, consultant3, Brendan Silbert, consultant4, Jennifer Hunt, research coordinator1, John R A Rigg, retired consultant5, Daniel I Sessler, professor and chair6 for the ANZCA Trials Group Investigators
+ Author Affiliations
1Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne, Australia
2Academic Board of Anaesthesia and Perioperative Medicine, Monash University, Melbourne
3Department of Anaesthesia, Austin Hospital, Heidelberg, Australia
4Department of Anaesthesia, St Vincents Hospital, Fitzroy, Australia
5Australian and New Zealand College of Anaesthetists Trials Group, Melbourne
6Department of Outcomes Research, Cleveland Clinic, Cleveland, USA
Correspondence to: P S Myles 
[email protected]
Accepted 31 January 2011
Abstract
Objective To compare long term recurrence of cancer and survival of patients having major abdominal surgery for cancer.
Design Long term follow-up of prospective randomised controlled clinical trial in which patients were randomly assigned to receive general anaesthesia with or without epidural block for at least three postoperative days.
Setting 23 hospitals in Australia, New Zealand, and Asia.
Participants 503 adult patients who had potentially curative surgery for cancer.
Main outcome measure Cancer-free survival (analysis was by intention to treat).
Results Long term follow-up data were available for 94% (n=446) of eligible participants. The median time to recurrence of cancer or death was 2.8 (95% confidence interval 0.7 to 8.7) years in the control group and 2.6 (0.7 to 8.7) years in the epidural group (P=0.61). Recurrence-free survival was similar in both epidural and control groups (hazard ratio 0.95, 95% confidence interval 0.76 to 1.17; P=0.61).
Conclusion Use of epidural block in abdominal surgery for cancer is not associated with improved cancer-free survival.